Skin dendritic cells in murine cutaneous leishmaniasis

Immunobiology

Volumn 204, Issue 5, 2001, Pages 590-594

  Udey, Mark C ^a   Von Stebut, Esther ^c   Mendez, Susana ^b   Sacks, David L ^b   Belkaid, Yasmine ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; NITRIC OXIDE; VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INTERACTION; CONTROLLED STUDY; DENDRITIC CELL; DRUG DESIGN; EVOLUTION; HELPER CELL; IMMUNOPATHOGENESIS; INOCULATION; INVOLUTION; LEISHMANIA MAJOR; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PARASITE CONTROL; PRIORITY JOURNAL; SKIN LEISHMANIASIS;

EID: 0035711157     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1078/0171-2985-00096     Document Type: Article

References (22)

1. The regulation of immunity to Leishmania major
2. Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice
3. Analysis of cytokine production by inflammatory mouse macrophages at the single-cell level: Selective impairment of IL-12 induction in Leishmania-infected cells
4. Parasitism of epidermal Langerhans cells in experimental cutaneous leishmaniasis with Leishmania major
5. Uptake of Leishmania major amastigotes results in activation and interleukin-12 release from murine skin-derived dendritic cells: Implications for the initiation of anti-Leishmania immunity
6. IL-12p70 production by Leishmania major-harboring human dendritic cells is a CD40/CD40 ligand-dependent process
7. Langerhans cell transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen-specific T cells
8. Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response
9. Murine epidermal Langerhans cells are potent stimulators of an antigen-specific T cell response to Leishmania major, the cause of cutaneous leishmaniasis
10. Antigen-pulsed epidermal Langerhans cells protect susceptible mice from infection with the intracellular parasite Leishmania major
11. Leishmania major-infected murine Langerhans cell-like dendritic cells from susceptible mice release IL-12 after infection and vaccinate against experimental cutaneous leishmaniasis
12. The host response to Leishmania infection
13. Development of a natural model of cutaneous leishmaniasis: Powerful effects of vector saliva and salia preexposure on the long-term outcome of Leishmania major infection in the mouse ear dermis
14. A natural model of Leishmania major infection reveals a prolonged "silent" phase of parasite amplification in the skin before the onset of lesion formation and immunity
15. Langerhans cell migration in murine cutaneous leishmaniasis: Regulation by tumor necrosis factor α and interleukin-1β, and macrophage inflammatory protein-1α
16. CC chemokine receptor (CCR) 2 is required for Langerhans cell migration and localization of T helper cell type 1 (Th1)-inducing dendritic cells: Absence of CCR2 shifts the Leishmania major-resistant phenotype to a dominated by Th2 cytokines, B cell outgrowth, and sustained neutrophilic inflammation
17. Control of Th2 polarization by the chemokine monocyte chemoattractant protein-1
18. The potency and durability of DNA- and protein-based vaccines against Leishmania major evaluated using low-dose, intradermal challenge
19. Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major
20. + T cells
21. The resolution of lesions induced by Leishmania major in mice requires a functional Fas (APO-1, CD95) pathway of cytotoxicity
22. Parasitophorous vacuoles of Leishmania mexicana acquire macromolecules from the host cytosol via two independent routes